References
  1. MarchWA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25:544-51.
  2. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 2011;343:d6309.
  3. Joham AE, Boyle JA, Ranasinha S, Zoungas S, Teede HJ. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women’s Health. Hum Reprod 2014;29(4):802-8.
  4. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-8.
  5. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12: 673-83.
  6. Angelica Lindén Hirschberg. Polycystic ovary syndrome, obesity and reproductive implications. Womens Health 2009, 5(5):529-42.
  7. Brassard M, AinMelk Y, Baillargeon JP. Basic infertility including polycystic ovary syndrome. Med Clin North Am 2008, 92, 1163-92.
  8. Laven JS, Imani B, Eijkemans MJ and Fauser BC. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 2002; 57,755-67.
  9. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:524–9.
  10. Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Practice & Research Clinical Endocrinology & Metabolism 2006, 20(2):235-44.
  11. Rotterdam ESHRE/SRM-sponsored PCOS Consensus Workshop Group. Revised 2003consensus on diagnostic criteria and long-term health risks related to polycystic ovarysyndrome (PCOS). Hum Reprod 2004;19:41-7.
  12. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-14.
  13. Shi W, Zhang S, Zhao W, Xia X, Wang M, Wang H, et al. Factors related to clinical pregnancy after vitrified-warmed embryo transfer: a retrospective and multivariate logistic regression analysis of 2313 transfer cycles. Hum Reprod 2013;28(7):1768-75.
  14. Cai H, Mol BW, Li P, Liu X, Watrelot A, Shi J. Tubal factor infertility with prior ectopic pregnancy: a double whammy? A retrospective cohort study of 2,892 women. Fertil Steril 2020;113(5):1032-8.
  15. Shi W, Xue X, Zhang S, Zhao W, Liu S, Zhou H, Wang M, Shi J. Perinatal and neonatal outcomes of 494 babies delivered from 972 vitrified embryo transfers, Fertil Steril 2012;97(6):1338-42.
  16. National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management.NG126.2019. https://www.nice.org.uk/guidance/ng126.
  17. Chu J, Hardy P, Beeson L, et al. What is the best method for managing early miscarriage? BMJ 2020;368:l6438
  18. Thompson D, Berger H, Feig D, Gagnon R, Kader T, Keely E, et al. Diabetes and pregnancy. Can J Diabetes 2013;37(Suppl 1):S168–83.
  19. Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment. J Assist Reprod Genet 2014;31(2):205-11.
  20. Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt) 2015;24(4):299-307.
  21. Joham AE, Boyle JA, Ranasinha S, Zoungas S, Teede HJ. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women’s Health. Hum Reprod 2014;29(4):802-8.
  22. Sahu B, Ozturk O, Ranierri M, Serhal P. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet 2008;277:239-44.
  23. Sterling L, Liu J, Okun N, Sakhuja A, Sierra S, Greenblatt E. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization. Fertil Steril 2016;105(3):791-7.e2.
  24. Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 2006;12(1):13-21.
  25. Hart R, Norman R. Polycystic ovarian syndrome–prognosis and outcomes. Best Pract Res Clin Obstet Gynaecol 2006;20:751-78.
  26. McCormick B, Thomas M, Maxwell R, Williams D, Aubuchon M. Effects of polycystic ovarian syndrome on in vitro fertilization embryo transfer outcomes are influenced by body mass index. Fertil Steril 2008;90:2304-9.
  27. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. Review. BJOG 2006, 113(10):1148-59.
  28. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001;16:226-9.
  29. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metabol Disord 2002; 26:883-96.
  30. Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab 2012;97:3251-60.
  31. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012;33:981-1030.
  32. Moran LJ, Norman RJ, Teede HJ. Metabolic risk in PCOS: phenotype and adiposity impact.Trends Endocrinol Metab 2015;26:136-43
  33. Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab 2015; (3):911-9.
  34. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001;16(2):226-9.
  35. Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365(9473):1807-16.
  36. Dickey RP, Taylor SN, Lu PY, et al. Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. Am J Obstet Gynecol 2002;186(1):77-83.
  37. Pinborg A, Lidegaard O, la Cour Freiesleben N, Andersen AN. Consequences of vanishing twins in IVF/ICSI pregnancies. Hum Reprod 2005;20(10):2821-9.
  38. Pinborg A, Lidegaard O, Freiesleben Nl, Andersen AN. Vanishing twins: a predictor of small-for-gestational age in IVF singletons. Hum Reprod 2007;22(10):2707-14.
  39. Bruyneel A, Catteau-Jonard S, Decanter C, et al. Syndrome des ovaires polymicrokystiques: une pathologie à risque obstétrical? Gynecol Obstet Fertil 2014;42(2):104-11.
  40. Naver KV, Grinsted J, Larsen SO, et al. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG 2014;121:575-81.